Use of Placebos and Post-Trial Benefits

DST. Jornal Brasileiro de Doencas Sexualmente Transmissiveis, v. 25, p. 169-170, 2014 (ISSN: 0103-4065)

2 Pages Posted: 29 Apr 2014 Last revised: 23 Dec 2014

See all articles by Ricardo Perlingeiro

Ricardo Perlingeiro

Fluminense Federal University - Faculty of Law; Estácio de Sá University - MA and PhD Programs in Law; Birmingham City University - Faculty of Business, Law and Social Sciences

Carmen Silvia Arruda

Universidade Federal Fluminense (UFF)

Date Written: 2014

Abstract

The text indicates some parameters for a comparative analysis of Brazil/United States on the use of placebos and post trial benefits in clinical trials.

Keywords: Health Care, Placebos, Post-Trial Benefits, Clinical Trials

JEL Classification: I18, K32, K23, K41, I11, I28, H75, H51

Suggested Citation

Perlingeiro, Ricardo and de Arruda, Carmen Silvia, Use of Placebos and Post-Trial Benefits (2014). DST. Jornal Brasileiro de Doencas Sexualmente Transmissiveis, v. 25, p. 169-170, 2014 (ISSN: 0103-4065). Available at SSRN: https://ssrn.com/abstract=2429661 or http://dx.doi.org/10.2139/ssrn.2429661

Ricardo Perlingeiro (Contact Author)

Fluminense Federal University - Faculty of Law ( email )

Rua Presidente Pedreira, 62
Niterói, 24210-470
Brazil

Estácio de Sá University - MA and PhD Programs in Law ( email )

Avenida Presidente Vargas, 642
Rio de Janeiro, 20071-001
Brazil

Birmingham City University - Faculty of Business, Law and Social Sciences ( email )

4 Cardigan Street
Birmingham, B4 7BD
United Kingdom

Carmen Silvia De Arruda

Universidade Federal Fluminense (UFF) ( email )

Núcleo de Ciências do Poder Judiciário - Nupej
Rua Professor Hernani Melo, nº 84, São Domingos
Niteroi, Rio DeJaneiro, 24.210-130
Brazil

Register to save articles to
your library

Register

Paper statistics

Downloads
132
Abstract Views
829
rank
220,744
PlumX Metrics